Furthermore, transgenic mice with GC-C activation demonstrated prominent gut microbial dysbiosis, emulating the microbiome of IBD and familial diarrheal syndrome patients with S840I mutation in GC-C (121). This evidence concerns the gene GUCY2C and irritable bowel syndrome.